Medical imaging is an integral part of managing cancer patients and in the evaluation of new therapies in clinical trials. This webinar will summarize and highlight the various types of imaging and their role in the clinic and in research, with a perspective on the regulatory aspects that govern its use and practical aspects for pharma, biotech and contract research organizations.
Attend this webinar to understand the:
- Role of imaging in managing cancer patients and in clinical research
- Importance of quantitative imaging and standardized reporting in clinical trials
- Emerging issues with imaging in immuno-oncology and with novel targeted therapies
- Regulatory landscape on the use of imaging in clinical trials
- Practical considerations for biopharma for the use of imaging in clinical trials
Souhil Zaim, MD, Head of Global Medical and Science Affairs, Bioclinica
Dr. Zaim is a recognized medical imaging industry senior executive with more than 25 years of medical, scientific and industry experience and was most recently chief medical officer at Median Technologies. He is responsible for ensuring the strategic and long-term medical, scientific and technical development of Bioclinica’s Medical and Science Affairs organization in concert with the Medical Imaging and Biomarkers’ Chief Medical Officer, Dr. Michael O’Neal, and Chief Science Officer, Dr. Thomas Fuerst.
Dr. Zaim was previously with SYNARC (merged with Bioclinica in March 2014) for more than a decade in various leadership roles, including medical director, chief medical officer, vice president of radiology, and director of radiology services, Europe. In these roles, Dr. Zaim established and developed global medical and science affairs teams supporting an array of clinical trial indications. Dr. Zaim is regularly published in peer-reviewed journals, and has extensive central reading and adjudication experience encompassing thousands of patients in hundreds of clinical trials in Oncology, Arthritis, Osteoporosis and other areas.
Prior to this, he was assistant professor of Radiology at the University of California at San Francisco. He earned a medical degree from the University of Algiers and is board certified in Radiology with a certificate in Magnetic Resonance, both from the University of Paris. Dr. Zaim is a member of the Radiological Society of North America, the European Society of Radiology, Osteoarthritis Research Society International, and the American Society of Clinical Oncology.Message Presenter
Who Should Attend?
- Clinical Research
- Clinical Development
- Clinical Project Management
- Clinical Trial Study/Protocol Managers
- Medical Affairs
- Clinical Operations
- Regulatory Affairs
- Medical Monitors
- Imaging Leads
- Medical Oncologists
Bioclinica is a specialty services provider that utilizes expertise and technology to create clarity in the clinical trial process. Bioclinica is organized by three business segments to deliver focused service supporting multifaceted technologies. The Medical Imaging and Biomarkers segment provides medical imaging and cardiac safety services and includes a molecular marker laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, Bioclinica offers a network of research sites, patient recruitment-retention solutions, and a post-approval research division.